These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S; J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447 [TBL] [Abstract][Full Text] [Related]
4. Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis. Ahmadi N; Nabavi V; Hajsadeghi F; Zeb I; Flores F; Ebrahimi R; Budoff M Int J Cardiol; 2013 Oct; 168(3):2310-4. PubMed ID: 23453866 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592 [TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247 [TBL] [Abstract][Full Text] [Related]
7. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG; Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial evaluating the effect of aged garlic extract with supplements versus placebo on adipose tissue surrogates for coronary atherosclerosis progression. Zeb I; Ahmadi N; Flores F; Budoff MJ Coron Artery Dis; 2018 Jun; 29(4):325-328. PubMed ID: 29140808 [TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304 [TBL] [Abstract][Full Text] [Related]
10. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022 [TBL] [Abstract][Full Text] [Related]
11. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years. Wolters M; Hermann S; Hahn A Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436 [TBL] [Abstract][Full Text] [Related]
12. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. Ky B; Burke A; Tsimikas S; Wolfe ML; Tadesse MG; Szapary PO; Witztum JL; FitzGerald GA; Rader DJ J Am Coll Cardiol; 2008 Apr; 51(17):1653-62. PubMed ID: 18436117 [TBL] [Abstract][Full Text] [Related]
13. Aged garlic extract improves endothelial function in men with coronary artery disease. Williams MJ; Sutherland WH; McCormick MP; Yeoman DJ; de Jong SA Phytother Res; 2005 Apr; 19(4):314-9. PubMed ID: 16041725 [TBL] [Abstract][Full Text] [Related]
14. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A; J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114 [TBL] [Abstract][Full Text] [Related]
15. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687 [TBL] [Abstract][Full Text] [Related]
16. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries. Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623 [TBL] [Abstract][Full Text] [Related]
17. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients. Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224 [TBL] [Abstract][Full Text] [Related]
18. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation). Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA; Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424 [TBL] [Abstract][Full Text] [Related]
19. A controlled trial of homocysteine lowering and cognitive performance. McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]